Not to harsh your mellow, but a new study suggests that labelling of marijuana, even by medical growers, is frequently inaccurate.

Dr. Jonathan Page of UBC's Department of Botany says users who seek out specific strains for medical or other reasons will often find their weed is not as advertised.

"Those classifications are actually quite inaccurate. The plants that were reported to be sativa were often not genetically sativa, and vice versa with indica as well," he said.

Dr. Page studied the DNA of 81 strains of marijuana from a medical grower in Ontario when he found the dubious labelling, suggesting this problem goes beyond illegal growers.

SMITHS FALLS, Ont. — Tweed Marijuana Inc. is reporting its first profitable quarter since receiving a federal licence to produce and sell medical cannabis.

The Ontario-based company, the first marijuana manufacturer in Canada to be publicly traded, earned a net profit of $1 million or two cents per share in the three months ended June 30. A year earlier, it had a net loss of $1.16 million or three cents per share.

Revenue for the first quarter of its financial year was $1.7 million, up 39 per cent from the previous quarter and nine times the less than $189,000 achieved a year ago, when commercial shipments began.

Mettrum Begins Cannabis Extracts Production

TORONTO, ONTARIO--(Marketwired - Aug. 31, 2015) -Mettrum Health Corp. ("Mettrum" or the "Company") (TSX VENTURE:MT)(TSX VENTURE:MT.WT), a vertically integrated agri-pharmaceutical company focused on research, development, production and distribution of medical cannabis products, is pleased to announce that it has received a supplemental license from Health Canada for the production of cannabis extracts effective immediately. 

Tweed Marijuana, a publicly traded medicinal marijuana company on the Toronto Stock Exchange-Venture board (TWD), announced Monday morning that the company had completed its merger with Bedrocan Cannabis in an all-stock deal valued at about CDN$61 million on the day the arrangement was first announced in June.

Tweed is Canada’s first publicly traded medical marijuana company and Bedrocan is a clinical research firm that claims to be one of only two companies in the world currently capable of producing standardized full-bud, pharmaceutical grade medicinal cannabis. Bedrocan operates as a division of Tweed, and Bedrocan’s shareholders own approximately 40% of the merged companies. Tweed shareholders own about 60%.

A meeting of the city's Planning Advising Committee (PAC) on Monday saw the committee approve a motion for establishing criteria for medical marijuana facilities.

Senior planner Mary Joyce-Smith presented the report to council and members of the public.

"What it's doing is setting up a critieria. You're always going to put it through site-plan [and] be aware of the regulations," Joyce-Smith said.

Joyce-Smith noted that there would be a 150-metre setback in residential areas for medical marijuana facilities and that all facilities would be located indoors.

TORONTO , Aug. 24, 2015 /CNW/ - At a special meeting held today, shareholders of Bedrocan Cannabis Corp. (BED.V) ("the Company" or "Bedrocan") overwhelmingly approved the proposed plan of arrangement (the "Arrangement") involving the acquisition by Tweed Marijuana Inc. (TWD.V) ("TMI" or "Tweed") of all of the issued and outstanding common shares of Bedrocan. The Arrangement remains subject to the final approval of the Superior Court of Justice of Ontario at a hearing scheduled to be held on August 26, 2015 and subject to satisfaction or waiver of all other conditions specified in Bedrocan's management information circular dated July 20, 2015 .

The sale of booze in supermarkets is a nice idea of you like a drink; it’s hell on those who have trouble with their drinking.

The newspapers unfurl on the kitchen table every morning, and for an hour I am an old-school general of the news, absorbing fresh troop movements and daily atrocities.

It is early and I am not done with coffee, nor have I eaten an orange or an egg, when the LCBO ad insert falls out of the paper, and I suddenly feel the need for clear gin in bottles blue or green, and a pale cold glass of pilsner, and rye whiskey splashed over crystal cubes of ice and, yes, a delicate glass of wine as dark as blood.

It is not yet 8:00 a.m.

TORONTO – When Sarah Stuive first got into the natural pest control business – which uses predatory insects, or “good bugs,” to weed out pests – she never expected to be working with cannabis plants.

But thanks to Health Canada regulations that limit the use of chemical pesticides on medical marijuana in order to make sure the plants are safe for consumption, the biological control specialist says she’s seeing an uptick in business.

“I have seen a lot of growth in demand since the start of the cannabis industry,” said Stuive, who works for Global Horticultural and also provides her services to vegetable farmers and plant growers. “It’s a new alternative to chemicals.”

SMITHS FALLS, ON , Aug. 20, 2015 /CNW/ - Tweed Marijuana Inc. ("TMI" or "the Company") (TWD.V) is pleased to announce that its wholly owned subsidiary, Tweed Inc. (Tweed) has received authorization from Health Canada to begin the production of cannabis extracts in the Company's state-of-the-art facility in Smiths Falls, Ontario .

Tweed will use preeminent pharmaceutical grade extraction methods to produce purified cannabis derivatives.

TORONTO, ONTARIO--(Marketwired - Aug. 19, 2015) - Abba Medix Group (CSE:ABA) wishes to report that its business arrangements with RedeCan Pharm and Blow Vapor are transforming in the face of rapidly changing conditions in the Canadian medical marijuana marketplace.

Abba Medix's Share Purchase Agreement for the acquisition of RedeCan Pharm lapsed on August 7, 2015. However, the companies have maintained a good working relationship and continue the discussion of a new agreement for Abba Medix to acquire RedeCan Pharm.

Abba Medix's Memorandum of Understanding with Blow Vapor expired July 31, 2015; however, the companies continue to discuss the potential of a new deal.